Trade Johnson & Johnson - JNJ CFD

Johnson & Johnson Company profile

What is Johnson & Johnson?

Johnson & Johnson is a holding company with its subsidiaries involved in the production and distribution of consumer healthcare products, medical devices and pharmaceutical products. Its consumer segment is represented by the brands Johnson's, Clean & Clear, Le Petite Marseillais and others. The pharmaceutical division ships products for almost all therapeutic fields and treatments for autoimmune disorders. The medical division manufactures devices for orthopaedic, diabetes care and other fields.

Financial stability has been one of Johnson & Johnson’s hallmarks for decades. The company has raised its dividend for 55 successive years, and remains one of just two U.S. companies to have a triple-A credit rating.Fortune included Johnson & Johnson in its list of the largest American corporations.

Johnson & Johnson also prides itself on its corporate social responsibility, and sets out its values in a Credo. In it, the company declares: “We believe our first responsibility is to the doctors, nurses and patients, to mothers and fathers and all others who use our products and services […] We must constantly strive to reduce our costs in order to maintain reasonable prices […] Our suppliers and distributors must have an opportunity to make a fair profit.”

Who are the key people at Johnson & Johnson?

Alex Gorsky is Chairman of the Board of Directors and Chief Executive Officer. Other key figures include Chief Financial Officer Dominic Caruso; Joaquin Duato, Worldwide Chairman, Pharmaceuticals; Jorge Mesquita, Worldwide Chairman, Consumer; and Ashley McEvoy, Company Group Chairman, Consumer Medical Devices.

What is the modern history of Johnson & Johnson?

Johnson & Johnson was founded by three brothers in 1885, incorporated in 1887, and chaired by successive members of the Johnson family until 1963. The company was listed in 1944 and steadily expanded from its home market to Latin America, Europe, Africa and Asia. In 1959, Johnson & Johnson acquired pharmaceutical manufacturer Cilag AG – a big landmark for its pharmaceutical division. The medical and consumer health divisions saw major growth in the latter decades of the 20thcentury.

What are the latest developments at Johnson & Johnson?

In its full year 2017 results, Johnson & Johnson reported worldwide sales of $76.5 billion, an increase of 6.3% on the previous year.Excluding the impact of acquisitions and divestitures, worldwide sales for 2017 were 2.4% higher than in 2016.Net earnings for the full year 2017 were $1.3 billion, and adjusted full year earnings per share were $7.30, an increase of 8.5% on 2016.

The Johnson & Johnson share price, which hovered between $50 and $60 for most of the first decade of this century, started taking off in 2012. By May 2014 the shares were trading at over $100, and in January 2018 they went as high as $147. As of 3 April 2018, they stood at just over $127. To find out how the shares are doing right now, follow Capital.com. Our JNJ chart puts all the information at your fingertips.

Where does Johnson & Johnson operate?

Johnson & Johnson is headquartered in New Brunswick in the U.S. state of New Jersey. The company’s 250 or so subsidiaries operate in 60 countries around the world, and its products are sold in more than 175 countries. So it’s a truly global company, with high levels of brand recognition.

Where is Johnson & Johnson traded?

Johnson & Johnson is listed on the New York Stock Exchange (NYSE), and the shares are a component of the Dow Jones Industrial Average. Check out Capital.com for the latest JNJ chart. We’ll keep you up to date and in the picture.